Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, PR China.
Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, PR China.
Eur J Surg Oncol. 2021 Jul;47(7):1526-1534. doi: 10.1016/j.ejso.2021.01.032. Epub 2021 Feb 4.
The influence of positive microscopic margin (R1) resection on the prognosis of gastrointestinal stromal tumors (GISTs) is controversial. Tumor rupture is significantly associated with the occurrence of R1 resection and may be a confounder of R1 resection in GISTs. The present meta-analysis evaluated the real influence of R1 resection on the prognosis of GISTs by excluding the confounding effect of tumor rupture.
The PubMed, Embase, Web of Science, Cochrane Central Register of Controlled Trials (CENTRAL), and ClinicalTrials.gov databases were searched. Studies that compared R1 with negative microscopic margin (R0) resection in GIST patients and reported the time-to-event data of recurrence-free survival (RFS) or disease-free survival (DFS) were eligible for inclusion. The quality of the observational studies was assessed using the Newcastle-Ottawa scale.
Of the 4896 records screened, 23 retrospective studies with 6248 participants were selected. In the overall analysis, R1 resection resulted in a significantly shorter RFS/DFS than R0 resection for GISTs (HR = 1.80, 95% CI = 1.54-2.10, P < 0.001, I = 14%). However, the inferior RFS/DFS vanished when tumor rupture cases were excluded (HR = 1.34, 95% CI = 0.98-1.83, P = 0.07, I = 33%). Sensitivity analysis by high-quality studies brought about a more robust HR of 1.15 (95% CI = 0.88-1.50, P = 0.29), with low heterogeneity (I = 0%). The qualities of evidence for the outcomes were high.
This meta-analysis shows that R1 resection did not influence the survival outcome of GISTs. Reresection may not be necessary when positive microscopic margins exist. This analysis could provide high-quality evidence for the development of guidelines.
阳性显微镜切缘(R1)切除对胃肠道间质瘤(GISTs)预后的影响存在争议。肿瘤破裂与 R1 切除的发生显著相关,可能是 GISTs 中 R1 切除的混杂因素。本荟萃分析通过排除肿瘤破裂的混杂效应,评估 R1 切除对 GISTs 预后的实际影响。
检索 PubMed、Embase、Web of Science、Cochrane 中心对照试验注册库(CENTRAL)和 ClinicalTrials.gov 数据库。纳入比较 GIST 患者 R1 与阴性显微镜切缘(R0)切除并报告无复发生存(RFS)或无病生存(DFS)时间事件数据的研究。使用纽卡斯尔-渥太华量表评估观察性研究的质量。
在筛选的 4896 条记录中,选择了 23 项回顾性研究,共 6248 名参与者。在总体分析中,R1 切除与 R0 切除相比,GISTs 的 RFS/DFS 明显缩短(HR=1.80,95%CI=1.54-2.10,P<0.001,I=14%)。然而,当排除肿瘤破裂病例时,较差的 RFS/DFS 消失(HR=1.34,95%CI=0.98-1.83,P=0.07,I=33%)。高质量研究的敏感性分析得出了更稳健的 HR 为 1.15(95%CI=0.88-1.50,P=0.29),异质性较低(I=0%)。这些结局的证据质量很高。
本荟萃分析表明,R1 切除并不影响 GISTs 的生存结局。当存在阳性显微镜切缘时,可能不需要再次切除。本分析可为指南的制定提供高质量的证据。